celecoxib has been researched along with ng-nitroarginine methyl ester in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (46.67) | 29.6817 |
| 2010's | 8 (53.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asfaha, S; Elliott, SN; Lovren, F; Muscará, MN; Triggle, CR; Vergnolle, N; Wallace, JL | 1 |
| Camici, G; Fiedler, M; Fratton, A; Gay, RE; Gay, S; Hellermann, JP; Hermann, M; Hurlimann, D; Lüscher, TF; Neidhart, M; Ruschitzka, F; Tanner, FC; Thiery, J | 1 |
| Fiorucci, S; Hollenberg, MD; von der Weid, PY; Wallace, JL | 1 |
| Becker, TL; Gambero, A; Maróstica, M; Pedrazzoli, J | 1 |
| Eltze, M; Grebe, T; Hatzelmann, A; Klein, T; Kömhoff, M | 1 |
| Chen, S; Hu, D; Liu, X; Wang, Y | 1 |
| Antunes, E; Desouza, IA; Ferreira, T; Macedo, ML; Mariano, NS; Mello, GC | 1 |
| Hashitani, S; Kishimoto, H; Noguchi, K; Ohtsu, N; Segawa, E; Takaoka, K; Urade, M | 1 |
| Dehpour, AR; Hajimirzabeigi, A; Khalilzadeh, O; Maleki, F; Zandieh, A; Zandieh, B | 1 |
| Banerjee, SK; Bulani, Y; Gupta, P; Kanwal, A; Kuncha, M; Putcha, UK; Sojitra, B | 1 |
| Abd El-Aal, SA; El-Sawalhi, MM; Kenawy, SA; Seif-El-Nasr, M | 1 |
| Del Valle-Mondragón, L; Guzmán-Hernández, EA; Ibarra-Barajas, M; Pastelín-Hernández, G; Sánchez-Mendoza, MA; Villalobos-Molina, R | 1 |
| Abo-Elmatty, DM; El-Baz, AA; Ibrahim, A; Mosaad, SM; Moustafa, YM; Zaitone, SA | 1 |
| Bauk, L; Drmic, D; Ilic, S; Kolenc, D; Luetic, K; Seiwerth, S; Sever, M; Sikiric, P; Suran, J; Zenko Sever, A | 1 |
| Abraham, D; Al-Jaber, M; Bakhamis, A; Bashah, M; Clapp, LH; Mohamed-Ali, V; Orie, NN; Raees, A | 1 |
15 other study(ies) available for celecoxib and ng-nitroarginine methyl ester
| Article | Year |
|---|---|
Selective cyclo-oxygenase-2 inhibition with celecoxib elevates blood pressure and promotes leukocyte adherence.
Topics: Animals; Aorta, Thoracic; Blood Pressure; Celecoxib; Cell Adhesion; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Endothelins; Hypertension; In Vitro Techniques; Isoenzymes; Leukocytes; Male; Muscle Contraction; NG-Nitroarginine Methyl Ester; Norepinephrine; Platelet Aggregation; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Wistar; Sulfonamides; Vasoconstrictor Agents | 2000 |
Differential effects of selective cyclooxygenase-2 inhibitors on endothelial function in salt-induced hypertension.
Topics: Acetylcholine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diclofenac; Dinoprost; Endothelium, Vascular; Enzyme Inhibitors; F2-Isoprostanes; Hypertension; Interleukin-1; Isoenzymes; Lactones; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Oxidative Stress; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Inbred Dahl; Safety; Sodium Chloride, Dietary; Sulfonamides; Sulfones; Vasodilation | 2003 |
Aspirin-triggered, cyclooxygenase-2-dependent lipoxin synthesis modulates vascular tone.
Topics: Acetylcholine; Animals; Aorta; Aspirin; Blood Pressure; Celecoxib; Cyclooxygenase 2 Inhibitors; Endothelium, Vascular; Hydroxyurea; Lipoxins; Lipoxygenase Inhibitors; Male; Mesenteric Arteries; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroarginine; Oligopeptides; Pyrazoles; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Lipoxin; Sulfonamides; Vascular Resistance; Vasodilation; Vasodilator Agents | 2004 |
Effect of different cyclooxygenase inhibitors on gastric adaptive cytoprotection induced by 20% ethanol.
Topics: Animals; Celecoxib; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Cytoprotection; Diclofenac; Dinoprostone; Dose-Response Relationship, Drug; Enzyme Inhibitors; Ethanol; Gastric Acid; Gastric Mucosa; Ibuprofen; Irritants; Male; Meloxicam; Membrane Proteins; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Pyrazoles; Rats; Rats, Wistar; Stomach Ulcer; Sulfonamides; Thiazines; Thiazoles | 2007 |
Celecoxib dilates guinea-pig coronaries and rat aortic rings and amplifies NO/cGMP signaling by PDE5 inhibition.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aorta; Celecoxib; Coronary Vessels; Cyclic GMP; Endothelium, Vascular; Guanylate Cyclase; Guinea Pigs; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitroprusside; Oxadiazoles; Perfusion; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Purinones; Pyrazoles; Quinoxalines; Rats; Regional Blood Flow; Signal Transduction; Sildenafil Citrate; Sulfonamides; Sulfones; Vasodilator Agents | 2007 |
Cyclovirobuxine D ameliorates acute myocardial ischemia by K(ATP) channel opening, nitric oxide release and anti-thrombosis.
Topics: Acute Disease; Animals; Animals, Newborn; Celecoxib; Cell Hypoxia; Cell Survival; Cells, Cultured; Coronary Thrombosis; Cyclooxygenase 2 Inhibitors; Drugs, Chinese Herbal; Endothelial Cells; Estrogen Antagonists; Glyburide; Myocardial Ischemia; Myocytes, Cardiac; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Potassium Channel Blockers; Potassium Channels, Inwardly Rectifying; Pyrazoles; Rats; Rats, Sprague-Dawley; Sulfonamides; Tamoxifen | 2007 |
Mechanisms involved in the rat peritoneal leukocyte migration induced by a Kunitz-type inhibitor isolated from Dimorphandra mollis seeds.
Topics: Analysis of Variance; Animals; Benzoquinones; Celecoxib; Cell Movement; Dexamethasone; Fabaceae; Indomethacin; Inflammation; Leukocytes; Male; NG-Nitroarginine Methyl Ester; Peptides; Peritoneal Lavage; Piperidines; Plant Proteins; Pyrazoles; Quinuclidines; Rats; Rats, Wistar; Seeds; Sulfonamides | 2009 |
Antitumor effects of inhibitors of nitric oxide synthase or cyclooxygenase-2 on human KB carcinoma cells overexpressing COX-2.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Enzyme Inhibitors; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; KB Cells; Mice; Mice, Inbred BALB C; Mice, Nude; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Pyrazoles; Sulfonamides; Up-Regulation; Xenograft Model Antitumor Assays | 2010 |
Anticonvulsant effect of celecoxib on pentylenetetrazole-induced convulsion: Modulation by NO pathway.
Topics: Animals; Anticonvulsants; Arginine; Celecoxib; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Epilepsy; Male; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pentylenetetrazole; Pyrazoles; Statistics, Nonparametric; Sulfonamides | 2010 |
Nitric oxide synthase inhibition abrogates hydrogen sulfide-induced cardioprotection in mice.
Topics: Animals; Biomarkers; Cardiotonic Agents; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Gene Expression; Heart; Heart Injuries; Hydrogen Sulfide; Isoproterenol; Male; Mice; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Organ Size; Oxidative Stress; Pyrazoles; Sulfonamides; Thiobarbituric Acid Reactive Substances; Tumor Necrosis Factor-alpha | 2012 |
Effect of celecoxib and L-NAME on global ischemia-reperfusion injury in the rat hippocampus.
Topics: Animals; Caspase 3; Celecoxib; Cyclooxygenase 2 Inhibitors; Hippocampus; Neuroprotective Agents; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide Synthase; Nitrites; Pyrazoles; Rats; Reperfusion Injury; Sulfonamides; Time Factors | 2013 |
Early co-expression of cyclooxygenase-2 and renin in the rat kidney cortex contributes to the development of N(G)-nitro-L-arginine methyl ester induced hypertension.
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Captopril; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Gene Expression Regulation; Hypertension, Renal; Kidney Cortex; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Peptide Fragments; Random Allocation; Rats, Wistar; Renin; RNA, Messenger | 2015 |
Celecoxib aggravates cardiac apoptosis in L-NAME-induced pressure overload model in rats: Immunohistochemical determination of cardiac caspase-3, Mcl-1, Bax and Bcl-2.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Blood Pressure; Cardiomegaly; Caspase 3; Celecoxib; Creatine Kinase, MB Form; Disease Models, Animal; DNA Fragmentation; L-Lactate Dehydrogenase; Male; Myeloid Cell Leukemia Sequence 1 Protein; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar | 2017 |
Celecoxib-induced gastrointestinal, liver and brain lesions in rats, counteraction by BPC 157 or L-arginine, aggravation by L-NAME.
Topics: Animals; Anti-Ulcer Agents; Antidotes; Arginine; Brain; Celecoxib; Chemical and Drug Induced Liver Injury; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Liver; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Peptide Fragments; Proteins; Rats; Rats, Wistar; Stomach; Stomach Ulcer | 2017 |
Altered cyclooxygenase-1 and enhanced thromboxane receptor activities underlie attenuated endothelial dilatory capacity of omental arteries in obesity.
Topics: Adipose Tissue; Adult; Apamin; Arteries; Celecoxib; Charybdotoxin; Cyclooxygenase 1; Cyclooxygenase Inhibitors; Endothelial Cells; Endothelium, Vascular; Female; Gastroepiploic Artery; Humans; Indomethacin; Male; Middle Aged; Muscle Relaxation; NG-Nitroarginine Methyl Ester; Obesity, Morbid; Omentum; Receptors, Thromboxane; Vasodilation | 2019 |